Autolus Therapeutics PLC Virtual Event To Discuss Autolus's Obe-cel Program In Systemic Lupus Erythematosus Transcript
Hello, ladies and gentlemen, and welcome to this Autolus event to discuss the new opportunity for Obe-cel and SLE. As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Julia Wilson. Please go ahead.
Thank you, Gigi. Good morning or good afternoon, everyone, and thank you for joining us to take part in today's SLE call. I am Julia Wilson, Communications Consultant for Autolus. With me today are Dr. Christian Itin, our Chief Executive Officer; Dr. Edgar Braendle, our Chief Development Officer; and Dr. Maria Leandro, Consultant, rheumatologists and Associate Professor at UCL Hospital in UCL and a key thought leader in the SLE space.
Before we begin, I would like to remind you that during today's call, we will make statements related to our business that are forward-looking under federal securities laws and the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
These may include, but are not limited to, statements regarding the development or
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |